Ceridian HCM Holding Inc. (NYSE:CDAY) CFO Sells $201,915.00 in Stock

Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) CFO Noemie Clemence Heuland sold 3,500 shares of Ceridian HCM stock in a transaction on Thursday, May 5th. The shares were sold at an average price of $57.69, for a total value of $201,915.00. Following the completion of the sale, the chief financial officer now directly owns 57,075 shares of the company’s stock, valued at $3,292,656.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Noemie Clemence Heuland also recently made the following trade(s):

• On Wednesday, March 9th, Noemie Clemence Heuland sold 592 shares of Ceridian HCM stock. The shares were sold at an average price of $62.49, for a total value of $36,994.08.

CDAY opened at $54.89 on Friday. Ceridian HCM Holding Inc. has a 52-week low of $52.79 and a 52-week high of $130.37. The firm has a market capitalization of $8.35 billion, a PE ratio of -99.80 and a beta of 1.51. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.11. The business’s 50-day simple moving average is $63.48 and its 200 day simple moving average is $86.06.

Ceridian HCM (NYSE:CDAY – Get Rating) last released its earnings results on Wednesday, May 4th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.05. The business had revenue of $293.30 million for the quarter, compared to analyst estimates of $289.44 million. Ceridian HCM had a negative return on equity of 3.09% and a negative net margin of 7.72%. Ceridian HCM’s revenue was up 25.1% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.03) earnings per share. On average, research analysts forecast that Ceridian HCM Holding Inc. will post -0.37 earnings per share for the current year.

Several research firms have recently commented on CDAY. Cowen lowered their target price on Ceridian HCM from $90.00 to $75.00 in a research note on Thursday. BMO Capital Markets lowered their target price on Ceridian HCM from $91.00 to $83.00 in a research note on Thursday. Credit Suisse Group began coverage on Ceridian HCM in a research note on Wednesday, March 23rd. They issued an “outperform” rating and a $85.00 target price for the company. Cowen lowered their target price on Ceridian HCM from $90.00 to $75.00 in a research note on Thursday. Finally, Barclays decreased their price objective on Ceridian HCM from $83.00 to $60.00 and set an “underweight” rating for the company in a research note on Tuesday, April 19th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $85.25.

A number of large investors have recently added to or reduced their stakes in the business. Capital Research Global Investors raised its stake in Ceridian HCM by 1.0% in the fourth quarter. Capital Research Global Investors now owns 18,543,250 shares of the company’s stock valued at $1,937,032,000 after buying an additional 187,146 shares during the period. Select Equity Group L.P. raised its stake in Ceridian HCM by 15.3% in the fourth quarter. Select Equity Group L.P. now owns 12,263,210 shares of the company’s stock valued at $1,281,015,000 after buying an additional 1,627,434 shares during the period. BlackRock Inc. grew its position in shares of Ceridian HCM by 1.9% in the fourth quarter. BlackRock Inc. now owns 9,113,436 shares of the company’s stock valued at $951,989,000 after purchasing an additional 171,398 shares during the last quarter. Janus Henderson Group PLC grew its position in shares of Ceridian HCM by 0.7% in the third quarter. Janus Henderson Group PLC now owns 6,645,804 shares of the company’s stock valued at $748,451,000 after purchasing an additional 47,989 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Ceridian HCM by 0.8% in the fourth quarter. JPMorgan Chase & Co. now owns 5,946,893 shares of the company’s stock valued at $621,213,000 after purchasing an additional 48,560 shares during the last quarter.

About Ceridian HCM (Get Rating)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.

Read More